Actively Recruiting
Development and Validation of a Personalized Digital Healthcare Model for Managing Side Effects in Breast Cancer Survivors
Led by Samsung Medical Center · Updated on 2024-12-11
72
Participants Needed
1
Research Sites
28 weeks
Total Duration
On this page
Sponsors
S
Samsung Medical Center
Lead Sponsor
P
Pusan National University Yangsan Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The ultimate goal of this research and development is to develop personalized digital healthcare technologies and self-management strategies based on self-assessment results and evidence, for breast cancer survivors who require management and recovery from acute and chronic side effects related to various treatments (surgery, chemotherapy, radiation, hormone therapy, etc.). Additionally, the aim is to verify the clinical applicability and establish a service model to address the diverse unmet healthcare needs of breast cancer survivors.
CONDITIONS
Official Title
Development and Validation of a Personalized Digital Healthcare Model for Managing Side Effects in Breast Cancer Survivors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Individuals who have undergone surgery for Stage 1-2 breast cancer
- Individuals who have had a unilateral mastectomy
- Aged 18 years or older and under 65 years
- Possessing a smartphone with either an Android or iOS operating system
- Individuals who voluntarily decide to participate after receiving detailed information about the study and provide written consent
You will not qualify if you...
- Individuals who have undergone mastectomy only and are not receiving chemotherapy, radiation, or hormone therapy
- Individuals with severe comorbidities such as underlying diseases, neuromuscular disorders, cognitive or mental impairments, visual disabilities, etc., that make it difficult to use the application or participate in the exercise intervention
- Individuals who undergo delayed breast reconstruction surgery during the study period
- Individuals who develop severe complications or experience cancer metastasis or recurrence in other organs during the study period leading to a change in treatment
- Occurrence of a major illness unrelated to study participation
- Failure to comply with the instructions of the study physician
- Situations where the participant voluntarily withdraws from the study or becomes unable to continue participating
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Samsung Medical Center
Seoul, Republic of Korea, South Korea, 06351
Actively Recruiting
Research Team
S
Sun Woo Kim, MS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here